Παρακολούθηση
Theodoros P. Vassilakopoulos
Theodoros P. Vassilakopoulos
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα med.uoa.gr - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Phase II study of the efficacy and safety of pembrolizumab for relapsed/refractory classic Hodgkin lymphoma
R Chen, PL Zinzani, MA Fanale, P Armand, NA Johnson, P Brice, ...
Journal of Clinical Oncology 35 (19), 2125-2132, 2017
10012017
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087
R Chen, PL Zinzani, HJ Lee, P Armand, NA Johnson, P Brice, J Radford, ...
Blood, The Journal of the American Society of Hematology 134 (14), 1144-1153, 2019
3032019
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
N Kalakonda, M Maerevoet, F Cavallo, G Follows, A Goy, JSP Vermaat, ...
The Lancet Haematology 7 (7), e511-e522, 2020
2652020
Clinical approach to lymphadenopathy
P GA
Seminars in oncology 20, 570-582, 1993
2251993
Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma
MC Kyrtsonis, TP Vassilakopoulos, N Kafasi, S Sachanas, T Tzenou, ...
British journal of haematology 137 (3), 240-243, 2007
2022007
Senescence and senotherapeutics: a new field in cancer therapy
V Myrianthopoulos, K Evangelou, PVS Vasileiou, T Cooks, ...
Pharmacology & therapeutics 193, 31-49, 2019
1692019
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s disease: associations with presenting features and clinical outcome
GZ Rassidakis, LJ Medeiros, S Viviani, V Bonfante, GP Nadali, ...
Journal of Clinical Oncology 20 (5), 1278-1287, 2002
1472002
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens
GZ Rassidakis, LJ Medeiros, TP Vassilakopoulos, S Viviani, V Bonfante, ...
Blood, The Journal of the American Society of Hematology 100 (12), 3935-3941, 2002
1392002
B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic …
GA Pangalis, MK Angelopoulou, TP Vassilakopoulos, MP Siakantaris, ...
Seminars in hematology 36 (2), 104-114, 1999
1391999
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care
TP Vassilakopoulos, GA Pangalis, A Katsigiannis, SG Papageorgiou, ...
The oncologist 17 (2), 239-249, 2012
1352012
A novel immunological assay for hepcidin quantification in human serum
V Koliaraki, M Marinou, TP Vassilakopoulos, E Vavourakis, E Tsochatzis, ...
PloS one 4 (2), e4581, 2009
1202009
A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies
MN Gamaletsou, TJ Walsh, T Zaoutis, M Pagoni, M Kotsopoulou, ...
Clinical Microbiology and Infection 20 (1), O50-O57, 2014
1192014
Rituximab monotherapy is highly effective in splenic marginal zone lymphoma
C Kalpadakis, GA Pangalis, MN Dimopoulou, TP Vassilakopoulos, ...
Hematological oncology 25 (3), 127-131, 2007
1192007
Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy
C Kalpadakis, GA Pangalis, MK Angelopoulou, S Sachanas, ...
The Oncologist 18 (2), 190-197, 2013
1002013
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma: associations with presenting features, serum …
M Herling, GZ Rassidakis, LJ Medeiros, TP Vassilakopoulos, KO Kliche, ...
Clinical cancer research 9 (6), 2114-2120, 2003
1002003
Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients: Experience from a single hematology unit
MC Kyrtsonis, T Vassilakopoulos, M Angelopoulou, M Siakantaris, ...
Annals of hematology 80, 722-727, 2001
992001
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma
L Mansouri, D Noerenberg, E Young, E Mylonas, M Abdulla, M Frick, ...
Blood, The Journal of the American Society of Hematology 128 (23), 2666-2670, 2016
982016
Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?
A Xochelli, C Kalpadakis, A Gardiner, P Baliakas, TP Vassilakopoulos, ...
Blood, The Journal of the American Society of Hematology 123 (8), 1199-1206, 2014
952014
Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders: A review
GA Pangalis, MN Dimopoulou, MK Angelopoulou, C Tsekouras, ...
Medical Oncology 18, 99-107, 2001
902001
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma
TP Vassilakopoulos, G Nadali, MK Angelopoulou, MP Siakantaris, ...
haematologica 86 (3), 274-281, 2001
892001
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20